#PrEP

Futuristic PrEP Tablets Can Signal Adherence to Regimen via Computer

Here are the HIV news stories with the most views this year.

Here are the HIV treatment news stories with the most views this year.

The new federal initiative will work with existing research programs in eight cities.

Gilead has based its entire HIV drug portfolio on updating tenofovir, ostensibly to make it safer for bones and kidneys.

Here are the top 20 philanthropic funders of HIV, according to an FCAA report, which also offers good news for the U.S. South and PrEP.

Members of the POZ Personals community share their experiences.

“This is definitely fantastic news and validates everything science has been saying.”

Truvada drugmaker Gilead Sciences promotes HIV prevention and PrEP.

NMAC offers support and engagement opportunities to advocates living with HIV who are 50 and over.

“It’s terrifying. It’s like coming out again,” actor Conrad Ricamora tells GLAAD.

But how will Cookie deal with her son’s HIV-positive lover?

The LA videos star women of color and promote HIV prevention. Watch all three here!

The study hopes to understand why Black women, who are at higher risk for HIV, are not likely to take PrEP.

ACT UP London connects PrEP, stigma and HIV-positive immigrants to the rock biopic about Queen and Freddie Mercury.

The Global HIV Vaccine Enterprise hopes to hasten the development of a safe and effective vaccine against the virus.

The federal initiative aims to help clinicians and their patients understand and access PrEP and PEP.